J. Zaia

发表

Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.

John J Rossi, Shirley Li, John Zaia, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Ribozymes as potential anti-HIV-1 therapeutic agents.

J. Rossi, E. Cantin, N. Sarver, 1990, Science.

Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

C. Crumpacker, M. Levin, J. Zaia, 1979, Antimicrobial Agents and Chemotherapy.

Design of HIV vectors for efficient gene delivery into human hematopoietic cells.

J. Yee, J. Zaia, P. Yam, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Hematopoietic cell transplantation with cord blood for cure of HIV infections.

J. Kurtzberg, E. Shpall, J. Rossi, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD13 (human aminopeptidase N) mediates human cytomegalovirus infection

J. Wahlberg, J. Zaia, S. Larsson, 1993, Journal of virology.

Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.

P. Feorino, J. Zaia, E. Palmer, 1975, The Journal of infectious diseases.

Creating genetic resistance to HIV.

J. Burnett, J. Rossi, J. Zaia, 2012, Current opinion in immunology.

KIR2DS2 and KIR2DS4 promoter hypomethylation patterns in patients undergoing hematopoietic cell transplantation (HCT).

J. Zaia, S. Forman, D. Senitzer, 2012, Human immunology.

Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases

P. Gregory, M. Holmes, P. Cannon, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes.

D. Kohn, G. Bauer, J. Zaia, 1997, Blood.

Hematopoietic potential and retroviral transduction of CD34+ Thy-1+ peripheral blood stem cells from asymptomatic human immunodeficiency virus type-1-infected individuals mobilized with granulocyte colony-stimulating factor.

J. Zaia, J. Moon, S. Forman, 1997, Blood.

CD19 CAR-T therapy and sepsis: dancing with the devil.

J. Zaia, L. Budde, 2018, Blood.

Differential detection of viral DNA and RNA in situ in cells infected with human cytomegalovirus.

J. Kaufman, J. Zaia, J. McCarrey, 1989, Journal of virological methods.

Large-scale manufacturing and characterization of CMV-CD19CAR T cells

Xiuli Wang, J. Zaia, S. Forman, 2022, Journal for ImmunoTherapy of Cancer.

Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella.

R. Ellis, M. Levin, J. Zaia, 1983, The Journal of infectious diseases.

CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells

Xiuli Wang, J. Zaia, A. Mardiros, 2015, Clinical Cancer Research.

CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges.

M. Donohoe, J. Zaia, C. Jamieson, 2018, Cell stem cell.

Lymphoma Cells in Patients Undergoing Transplantation for AIDS-Related + Modified CD 34 − RNA-Based Gene Therapy for HIV with Lentiviral Vector

A. Krishnan, M. Kalos, J. Rossi, 2010 .

Considerations for the clinical application of chimeric antigen receptor T cells: Observations from a Recombinant DNA Advisory Committee symposium held June 15, 2010 (Cancer Research (2011) 71, (3175-3181))

S. Rosenberg, C. June, J. Kahn, 2011 .

Brief Report: Nosocomial Infection Rates in a Cancer Treatment Center

J. Zaia, B. Tegtmeier, Gayle V. Robinson, 1984, Infection Control.

Acyclovir halts progression of herpes zoster in immunocompromised patients.

B. Bean, H. Balfour, J. Zaia, 1983, The New England journal of medicine.

CELLULAR IMMUNITY IN MULTIPLE SCLEROSIS

J. Zaia, H. Donnenfeld, H. Bartfeld, 1976, The Lancet.

Clinical evaluation of safety and immunogenicity of PADRE-cytomegalovirus (CMV) and tetanus-CMV fusion peptide vaccines with or without PF03512676 adjuvant.

B. Williams, J. Zaia, A. Krieg, 2012, The Journal of infectious diseases.

Advances in CMV Diagnostic Testing and Their Implications for the Management of CMV Infection in Transplant Recipients

J. Zaia, K. Molinder, 2001 .

Induction of poxviral immunity by synthetic MVA-based dual-antigen COVID-19 vaccine COH04S1

J. Zaia, D. Diamond, F. Chiuppesi, 2022, medRxiv.

Expression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infection.

J. Zaia, Lia Thao, S. Forman, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Expression of Activating KIR2DS2 and KIR2DS4 genes following hematopoietic cell transplant (HCT): relevance to cytomegalovirus (CMV) infection

J. Zaia, Lia Thao, D. Senitzer, 2011 .

Lack of association of cytomegalovirus with human brain tumors

A. Mamelak, J. Zaia, Wengang Chen, 2005, Modern Pathology.

Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients

J. Zaia, S. Forman, G. M. Schmidt, 1994, Journal of clinical microbiology.

Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study.

M. Boeckh, P. Southwick, J. Zaia, 2010, Blood.

COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus spike proteins

A. Cardoso, J. Ladner, J. Zaia, 2022, Cell Reports.

Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants

Anna M. Acosta, P. Frankel, J. Zaia, 2022, iScience.

Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity

I. Aldoss, J. Zaia, S. Forman, 2022, Blood Advances.

Copurification of P6, MRP8, and MRP14 from human granulocytes and separation of individual proteins.

J. Zaia, T. Vogl, J. Zaia, 1998, Protein expression and purification.

The immune response to herpes simplex virus: Comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections

R. Eberle, J. Zaia, S. Mou, 1985, Journal of medical virology.

DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A*0201 mice.

J. Zaia, Lia Thao, D. Diamond, 2004, Vaccine.

D. Kohn, G. Bauer, J. Zaia, 1997, Blood.

The status of gene vectors for the treatment of diabetes

J. Zaia, 2007, Cell Biochemistry and Biophysics.

Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cells.

J. Yee, M. Villacres, J. Zaia, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Donor killer immunoglobulin-like receptor genes and reactivation of cytomegalovirus after HLA-matched hematopoietic stem-cell transplantation: HLA-C allotype is an essential cofactor

J. Zaia, S. Forman, R. Nakamura, 2013, Front. Immun..

Quantitation of human cytomegalovirus DNA in lungs from bone marrow transplant recipients with interstitial pneumonia.

J. Zaia, S. Forman, N. Azumi, 1987, The Journal of infectious diseases.

Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.

G. Marcucci, J. Zaia, S. Forman, 2019, Leukemia research.

The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation.

J. Zaia, Lia Thao, S. Forman, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.

D. Snydman, N. Flournoy, M. Levin, 1983, Annals of internal medicine.

Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation.

J. Zaia, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Virion encapsidation of tRNA(3Lys)-ribozyme chimeric RNAs inhibits HIV infection.

J. Rossi, S. Westaway, J. Zaia, 1998, Antisense & nucleic acid drug development.

Inhibition of human immunodeficiency virus by using an oligonucleoside methylphosphonate targeted to the tat-3 gene

R. Eritja, J. Rossi, E. Cantin, 1988, Journal of virology.

Direct detection of HIV-1 RNA from AIDS and ARC patient samples.

J. Rossi, J. Zaia, B. Kaplan, 1988, DNA.

PREVALENCE OF ANTIBODY TO HUMAN HERPESVIRUS 6 AMONG BLOOD DONORS INFECTED WITH HIV

C. Hur, J. Zaia, J. Mosley, 1988, The Lancet.

Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A.

J. Zaia, 1991 .

Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy.

J. Zaia, S. Forman, J. Rosenthal, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased programmed death-1 molecule expression in cytomegalovirus disease and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

J. Zaia, Lia Thao, S. Forman, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increased PD-1 expression in CMV disease and acute GVHD after allogeneic HCT

J. Zaia, Lia Thao, D. Diamond, 2009 .

Viral disease prevention after hematopoietic cell transplantation

H. Einsele, M. Boeckh, P. Ljungman, 2009, Bone Marrow Transplantation.

Evaluation of a quantitative plasma PCR plate assay for detecting cytomegalovirus infection in marrow transplant recipients

J. Niland, J. Zaia, S. Forman, 1997, Journal of clinical microbiology.

In the Fog of Coronavirus Disease (COVID)

J. Zaia, 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

In the Fog of COVID.

J. Zaia, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

PretranspiantPulmonaryFunction PredictsCytomegalovirus-Associated InterstitialPneumoniafollowingBone MarrowTransplantation

J. Niland, J. Zaia, D. Horak, 2022 .

Genomic locus for a 140 kDa structural protein (pp150) of human cytomegalovirus in strains Towne and AD169.

J. Zaia, M. A. Churchill, H. Pande, 1989, Virus research.

Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group.

S. Azen, M. Fletcher, J. Zaia, 1989, Journal of acquired immune deficiency syndromes.

A rapid radioimmunoassay using 125I-labeled staphylococcal protein A for antibody to varicella-zoster virus.

D. Richman, J. Zaia, P. Cleveland, 1981, The Journal of infectious diseases.

Kinase‐Deficient CMVpp65 Triggers a CMVpp65 Specific T‐Cell Immune Response in HLA‐A*0201.Kb Transgenic Mice after DNA Immunization

J. Zaia, D. Diamond, G. Gallez-Hawkins, 2002, Scandinavian journal of immunology.

CD 13 ( Human Aminopeptidase N ) Mediates Human Cytomegalovirus Infection

J. Zaia, S. Larsson, T. D. Giugni, 2022 .

Prolonged human cytomegalovirus viremia following bone marrow transplantation.

J. Zaia, S. Forman, M. Gallagher, 1984, Transplantation.

The biology of human cytomegalovirus infection after bone marrow transplantation.

J. Zaia, 1986, International journal of cell cloning.

Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectors.

M. Zern, J. Rossi, D. Strayer, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Infection of human peripheral blood mononuclear cells by varicella-zoster virus.

R. Arbeit, M. Levin, J. Zaia, 1982, Intervirology.

Polypeptide specificity of the early antibody response following primary and recurrent genital herpes simplex virus type 2 infections.

R. Eberle, J. Zaia, S. Mou, 1984, The Journal of general virology.

Letter: Cellular immunity in multiple sclerosis.

J. Zaia, H. Donnenfeld, H. Bartfeld, 1976, Lancet.

Effect of Tetraethyllead on Learning and Memory in the Rat.

J. Bullock, J. Zaia, H. Schroeder, 1966 .

Hematologic Aspects of HIV/AIDS.

D. Scadden, J. Zaia, A. Levine, 2001, Hematology. American Society of Hematology. Education Program.

Status of Cytomegalovirus Prevention and Treatment in 2000.

M. Weekes, M. Wills, J. Sissons, 2000, Hematology. American Society of Hematology. Education Program.

Assessment of cellular immunity to human cytomegalovirus in recipients of allogeneic stem cell transplants.

J. Zaia, D. Diamond, S. Lacey, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic Cell Therapy for Human Immunodeficiency Virus Infection

A. Krishnan, J. Rossi, J. Zaia, 2016 .

Practical Considerations in Gene Therapy for HIV Cure

J. Zaia, R. Stan, 2014, Current HIV/AIDS Reports.

Development of Hematopoietic Stem Cell Based Gene Therapy for HIV-1 Infection: Considerations for Proof of Concept Studies and Translation to Standard Medical Practice

A. Krishnan, J. Rossi, Haitang Li, 2013, Viruses.

Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy.

Hung Fan, Alessandro Aiuti, Jacqueline Corrigan-Curay, 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

Viral Infections in Organ Transplant Recipients

J. Zaia, 2017 .

A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants

J. Niland, J. Zaia, S. Forman, 1991 .

Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients.

A. Nademanee, J. Zaia, S. Forman, 1988, Transplantation.

Cloning and physical mapping of a gene fragment coding for a 64-kilodalton major late antigen of human cytomegalovirus.

A. Riggs, J. Shively, J. Zaia, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.

G. Papanicolaou, R. Rubin, M. Boeckh, 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-up.

A. Nademanee, J. Niland, J. Zaia, 1995, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.

J. Niland, J. Zaia, S. Forman, 1991, The New England journal of medicine.

Infections in Organ Transplant Recipients

J. Zaia, 2009 .

Viral infections associated with bone marrow transplantation.

J. Zaia, 1990, Hematology/oncology clinics of North America.

Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients.

J. Zaia, Lia Thao, S. Forman, 2008, Blood.

Prevention and treatment of cytomegalovirus pneumonia in transplant recipients.

J. Zaia, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants

J. Zaia, S. Forman, D. Senitzer, 2002, Transplantation.

Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.

B. Storer, M. Boeckh, J. Zaia, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pretransplant pulmonary function predicts cytomegalovirus-associated interstitial pneumonia following bone marrow transplantation.

J. Niland, J. Zaia, S. Forman, 1992, Chest.

Comparative analysis of human cytomegalovirus a-sequence in multiple clinical isolates by using polymerase chain reaction and restriction fragment length polymorphism assays

J. Zaia, S. Forman, G. M. Schmidt, 1990, Journal of clinical microbiology.

Characterization of a 52K protein of murine cytomegalovirus and its immunological cross-reactivity with the DNA-binding protein ICP36 of human cytomegalovirus.

J. Shanley, J. Zaia, E. S. Creeger, 1991, The Journal of general virology.

Prophylaxis and treatment of CMV infections in transplantation.

J. Zaia, 1996, Advances in experimental medicine and biology.

Topical acyclovir treatment of herpes zoster in immunocompromised patients.

M. Levin, J. Zaia, L. Davis, 1985, Journal of the American Academy of Dermatology.

Biologic and Immunologic Effects of Knockout of Human Cytomegalovirus pp65 Nuclear Localization Signal

Xiwei Wu, J. Zaia, Lia Thao, 2009, Clinical and Vaccine Immunology.

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes

S. Riddell, P. Greenberg, J. Zaia, 1994, Journal of medical virology.

Human cytomegalovirus strain Towne pp65 gene: nucleotide sequence and expression in Escherichia coli.

J. Zaia, H. Pande, K. Campo, 1991, Virology.

Structural analysis of a 64-kDa major structural protein of human cytomegalovirus (Towne): identification of a phosphorylation site and comparison to pp65 of HCMV (AD169).

T. Lee, J. Zaia, M. A. Churchill, 1990, Virology.

Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010.

S. Rosenberg, C. June, J. Kahn, 2011, Cancer research.

Safety of Isavuconazonium Sulfate in Pediatrics Patients With Hematologic Malignancies and Hematopoietic Cell Transplantation With Invasive Fungal Infections: A Real World Experience

J. Zaia, Weili Sun, Sanjeet S. Dadwal, 2020, Journal of pediatric hematology/oncology.

Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells.

J. Zaia, M. Oxman, 1977, The Journal of infectious diseases.

Status of Ribozyme and Antisense‐Based Developmental Approaches for Anti‐HIV‐1 Therapy a

J. Rossi, J. Zaia, N. Taylor, 1992, Annals of the New York Academy of Sciences.

Ribozymes as anti-HIV-1 therapeutic agents: principles, applications, and problems.

J. Rossi, S. Sullivan, J. Zaia, 1992, AIDS research and human retroviruses.

Airborne transmission of chickenpox in a hospital.

D. Goldmann, M. Levin, J. Zaia, 1980, The New England journal of medicine.

Current status of gene therapy strategies to treat HIV/AIDS.

J. Rossi, R. Pomerantz, D. Strayer, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Prospects for Gene Therapy Using HIV-Based Vectors

J. Yee, J. Zaia, 2001, Somatic cell and molecular genetics.

Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes.

J. Rossi, C. Zhou, D. Kohn, 1994, Gene.

Immunosuppression and infection-progress.

M. Levin, J. Zaia, 1977, The New England journal of medicine.

HIV-associated non-Hodgkin lymphoma: viral origins and therapeutic options.

A. Krishnan, J. Zaia, 2014, Hematology. American Society of Hematology. Education Program.

Stem cell transplantation and gene therapy for HIV-related lymphomas.

A. Krishnan, J. Zaia, A. Molina, 2002, Journal of hematotherapy & stem cell research.

Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters

Tammy Chang, J. Yee, Shirley Li, 2007, Gene Therapy.

RNA‐Mediated Inhibition of HIV in a Gene Therapy Setting

J. Rossi, N. Lee, Shirley Li, 2003, Annals of the New York Academy of Sciences.

Novel ribozyme, RNA decoy, and siRNA approaches to inhibition of HIV in a gene therapy setting

J. Rossi, N. Lee, Shirley Li, 2003 .

Ribozymes as Therapies for AIDS a

J. Rossi, E. Cantin, N. Sarver, 1990, Annals of the New York Academy of Sciences.

Confirmation of HIV infection using gene amplification.

J. Rossi, J. Zaia, 1989, Transfusion Medicine Reviews.

A nucleolar TAR decoy inhibitor of HIV-1 replication

J. Rossi, Shirley Li, J. Zaia, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells

John A Zaia, Anitha Rao, Philip D. Gregory, 2016, Molecular therapy. Methods & clinical development.

Antiviral Evaluation of HIV-1 Specific Ribozyme Expressed in CD4+ HeLa Cells

J. Rossi, E. Cantin, N. Sarver, 1991 .

Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.

J. Rossi, J. Yee, Ming-jie Li, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Safety and Efficacy of a Lentiviral Vector Containing Three Anti-HIV Genes-CCR5 Ribozyme, Tat-rev siRNA, and TAR Decoy-in SCID-hu Mouse-Derived T Cells.

B. Palmer, J. Rossi, J. Yee, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.

John J Rossi, Shirley Li, John Zaia, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Novel Cell type-specific aptamer-siRNA delivery system for HIV-1 therapy

J. Rossi, Jiehua Zhou, Haitang Li, 2007 .

Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas.

David D. Smith, A. Krishnan, J. Zaia, 2005, Blood.

RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma

Anitha Rao, John J. Rossi, Shirley Li, 2010, Science Translational Medicine.

Problems and solutions to successful gene-transfer based therapies for HIV

J. Zaia, 2003 .

Bone Marrow Ablation Followed by Allogeneic Marrow Grafting During First Complete Remission of Acute Nonlymphocytic Leukemia

D. Findley, J. Fahey, R. Krance, 1983 .

Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemia.

Wayne, Zaia, D. Findley, 1983, Blood.

Immune response to herpesvirus antigens in adults with acute cytomegaloviral mononucleosis.

M. Hirsch, C. Rinaldo, M. Levin, 1979, The Journal of infectious diseases.

Towards an HIV cure: a global scientific strategy

M. Lederman, J. Mullins, A. Telenti, 2012, Nature Reviews Immunology.

Bone marrow transplantation for hematologic malignancies in patients aged 30 years or older.

D. Findley, J. Zaia, S. Forman, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytomegalovirus viral load and virus-specific immune reconstitution after peripheral blood stem cell versus bone marrow transplantation.

B. Storer, S. Riddell, T. Stevens-Ayers, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection

J. Zaia, D. Diamond, Sanjeet S. Dadwal, 2018, Expert review of vaccines.

Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma.

J. Niland, J. Zaia, S. Forman, 1997, The Journal of infectious diseases.

Human cytomegalovirus strain Towne pp28 gene: sequence comparison to pp28 of HCMV AD169 and stable expression in Chinese hamster ovary cells.

J. Zaia, H. Pande, K. Campo, 1991, Virology.

Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients.

A. Limaye, J. Zaia, Lia Thao, 2006, The Journal of infectious diseases.

Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens

M. Levin, J. Zaia, P. Leary, 1978, Infection and immunity.

Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 and HLA-B*07 alleles.

M. Villacres, J. Zaia, S. Forman, 2003, Human immunology.

Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years

J. Zaia, G. Hütter, 2011, Clinical and experimental immunology.

Bone marrow transplantation for acute nonlymphoblastic leukemia during first complete remission. An analysis of prognostic factors.

A. Nademanee, D. Findley, R. Krance, 1987, Transplantation.

Molecular and epidemiologic evaluations of a cluster of cases of Ménétrièr's disease associated with cytomegalovirus

J. Zaia, M. A. Churchill, A. Kovacs, 1993, The Pediatric infectious disease journal.

HIV status does not affect the outcome of autologous stem cell transplantation (ASCT) for non-Hodgkin lymphoma (NHL).

A. Krishnan, J. Zaia, S. Forman, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Neutralization of Human Cytomegalovirus by Human CD13-Specific Antibodies

K. Hedlund, J. Zaia, C. Söderberg, 1996, The Journal of infectious diseases.

Plasma Viremia and Cellular HIV-1 DNA Persist Despite Autologous Hematopoietic Stem Cell Transplantation for HIV-Related Lymphoma

A. Krishnan, J. Mellors, J. Rossi, 2013, Journal of acquired immune deficiency syndromes.

A chimeric tRNA(Lys3)-ribozyme inhibits HIV replication following virion assembly.

J. Rossi, S. Westaway, J. Zaia, 1995, Nucleic acids symposium series.

Autologous stem cell transplantation for HIV-associated lymphoma.

A. Nademanee, A. Krishnan, J. Zaia, 2001, Blood.

Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)-ribozymes under dual U6 snRNA and tRNA promoters.

J. Rossi, S. Westaway, Shirley Li, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Treatment of human immunodeficiency virus-related lymphoma with haematopoietic stem cell transplantation.

A. Krishnan, J. Zaia, A. Molina, 2003, Blood reviews.

Expression in insect cells and immune reactivity of a 28K tegument protein of human cytomegalovirus.

J. Zaia, M. Guha, T. D. Giugni, 1992, The Journal of general virology.

Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine

K. Morris, J. Burnett, Shasha Li, 2022, Molecular therapy. Methods & clinical development.

Pattern of T cell reconstitution following allogeneic bone marrow transplantation for acute hematological malignancy.

J. Bolen, J. Zaia, S. Forman, 1982, Transplantation.

MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.

I. Aldoss, J. Zaia, J. Longmate, 2017, Blood.

How I treat patients with HIV-related hematological malignancies using hematopoietic cell transplantation.

J. Zaia, S. Forman, J. Alvarnas, 2017, Blood.

Site-directed mutation in a conserved kinase domain of human cytomegalovirus-pp65 with preservation of cytotoxic T lymphocyte targeting.

J. Zaia, D. Diamond, G. Gallez-Hawkins, 2001, Vaccine.

Human cytomegalovirus-associated pneumonitis: pathogenesis, prevention, and treatment.

J. Zaia, S. Forman, A. Kovács, 1987, Transplantation proceedings.

Illusive Fever in the Newborn

J. Zaia, 1971, Clinical pediatrics.

Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients.

J. Zaia, S. Forman, K. Blume, 1986, The Journal of infectious diseases.

Increased Leu-7-positive T lymphocytes during cytomegalovirus infection following allogeneic bone marrow transplantation for hematologic malignancies.

J. Zaia, S. Forman, M. Gallagher, 1986, Transplantation.

Direct DNA immunization of mice with plasmid DNA encoding the tegument protein pp65 (ppUL83) of human cytomegalovirus induces high levels of circulating antibody to the encoded protein.

J. Zaia, S. Forman, H. Pande, 1995, Scandinavian journal of infectious diseases. Supplementum.

Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial.

I. Aldoss, Jeffrey S. Miller, J. Zaia, 2016, The Lancet. Haematology.

Infrequent Occurrence of Natural Mutations in the pp65495–503 Epitope Sequence Presented by the HLA A∗0201 Allele among Human Cytomegalovirus Isolates

J. Zaia, D. Diamond, Xiuli Li, 2001, Journal of Virology.

Simultaneous reconstitution of multiple cytomegalovirus-specific CD8+ cell populations with divergent functionality in hematopoietic stem-cell transplant recipients.

W. Haq, J. Zaia, Lia Thao, 2005, The Journal of infectious diseases.

A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector.

W. Britt, A. Mandarino, J. Zaia, 2008, Virology.

A 64,000 dalton matrix protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen.

K. Welte, J. Zaia, S. Forman, 1985, Journal of immunology.

Cost analysis of ganciclovir and foscarnet in recipients of allogeneic hematopoietic cell transplant with cytomegalovirus viremia

J. Zaia, J. Ito, J. Kriengkauykiat, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic hematopoietic stem cell transplantation: viremia, immunogenicity and survival outcomes in a randomised phase 1b trial

I. Aldoss, Jeffrey S. Miller, J. Zaia, 2015, The Lancet. Haematology.

Institution affects association between CMV seronegative graft and leukemic relapse after pediatric HCT.

J. Zaia, R. Nakamura, C. Behrendt, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection.

J. Zaia, Lia Thao, S. Forman, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplantation in HIV-infected subjects: is cure possible?

J. Zaia, S. Forman, 2013, Hematology. American Society of Hematology. Education Program.

Isolation and partial chemical characterization of a 64,000-dalton glycoprotein of human cytomegalovirus

J. Zaia, Y. Ting, B. R. Clark, 1984, Journal of virology.

Diagnosis of CMV.

J. Zaia, 1999, The Pediatric infectious disease journal.

Commentary (Forman/Zaia): Vaccinations Against Infectious Diseases in Hematopoietic Stem Cell Transplant Recipients

J. Zaia, S. Forman, 2003 .

High dose therapy and autologous stem cell transplantation for human immunodeficiency virus‐associated non‐Hodgkin lymphoma in the era of highly active antiretroviral therapy

A. Nademanee, A. Krishnan, J. Zaia, 2000, Cancer.

Genomic localization of the gene encoding a 32-kDa capsid protein of human cytomegalovirus.

J. Zaia, M. A. Churchill, H. Pande, 1988, Virology.